Olmesartan Medoxomilo + Hidroclorotiazida Generis (Olmesartan Medoxomil, Hydrochlorothiazide)

Olmesartan medoxil, the active ingredient in Olmesartan Medoxomilo + Hidroclorotiazida Generis, is an angiotensin II receptor blocker presented as a oral tablet for systemic use. It treats hypertension, often in combination with a diuretic, in adult patients. GNH USA supplies Olmesartan Medoxomilo + Hidroclorotiazida Generis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Olmesartan Medoxomilo + Hidroclorotiazida Generis as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals and pharmacies worldwide.

Olmesartan medoxil combined with hydrochlorothiazide is used primarily ​​ for managing blood pressure through the renin‑angiotensin‑aldosterone system pathway.

- Hypertension: Lowers systolic and diastolic blood pressure to reduce cardiovascular risk. - Hypertension with fluid retention: Improves blood‑pressure control when excess fluid contributes to elevated readings. - High‑risk cardiovascular patients with hypertension : Provides additional risk‑reduction benefits beyond blood‑pressure lowering.

Olmesartan medoxil with  hydrochloride    ​​     ​  ​  ​          ​  ​  …

Common Side Effects: -       ...  …  ... etc…  ...  t  ....  ....  t…  t … 

Serious or Rare Side ...  t ....  t .... """"""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""""

The  t  ...